C3orf33
Protein C3orf33
Also known as: AC3-33, CC033_HUMAN, FLJ31139
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6P1S2
- Gene
- C3orf33
- Ensembl
- ENSG00000174928
- Chromosome
- 3
- Canonical length
- 294 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
Involved in negative regulation of ERK1 and ERK2 cascade and regulation of DNA-binding transcription factor activity. Located in extracellular space. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
294 residues, UniProt reviewed canonical sequence.
>Q6P1S2|C3orf33
1 MAGQPAATGS PSADKDGMEP NVVARISQWA DDHLRLVRNI STGMAIAGIM LLLRSIRLTS
61 KFTSSSDIPV EFIRRNVKLR GRLRRITENG LEIEHIPITL PIIASLRKEP RGALLVKLAG
121 VELAETGKAW LQKELKPSQL LWFQLLGKEN SALFCYLLVS KGGYFSVNLN EEILRRGLGK
181 TVLVKGLKYD SKIYWTVHRN LLKAELTALK KGEGIWKEDS EKESYLEKFK DSWREIWKKD
241 SFLKTTGSDF SLKKESYYEK LKRTYEIWKD NMNNCSLILK FRELISRINF RRKGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against C3orf33 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 10 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 10 nTPM
- thyroid gland: 8.1 nTPM
- parathyroid gland: 7 nTPM
- pancreas: 6.3 nTPM
- kidney: 5.8 nTPM
- heart muscle: 5.7 nTPM
Single-cell type
- oocytes: 28 nCPM
- bergmann glia: 27 nCPM
- ependymal cells: 26 nCPM
- other brain neurons: 25 nCPM
- brain excitatory neurons: 24 nCPM
- brain inhibitory neurons: 22 nCPM
Immune cell
- MAIT T-cell: 5.1 nTPM
- NK-cell: 4.2 nTPM
- naive CD8 T-cell: 4.1 nTPM
- gdT-cell: 4 nTPM
- naive CD4 T-cell: 3.9 nTPM
- memory CD8 T-cell: 3.6 nTPM
Brain region
- choroid plexus: 4.4 nTPM
- cerebral cortex: 3.9 nTPM
- hypothalamus: 3.2 nTPM
- basal ganglia: 3 nTPM
- hippocampal formation: 2.8 nTPM
- thalamus: 2.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.41
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.41
- DepMap mean gene effect
- 0.15
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SNase-like, OB-fold superfamily
- Protein C3orf33-like
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads C3orf33 as an antibody target. Whether an autoantibody or antibody against C3orf33 could matter depends on whether native C3orf33 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
C3orf33 is annotated as secreted, so native C3orf33 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label C3orf33 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...